From "Inclusion in What" to "Equity in What": (Re)Thinking the Question of In/Equity in Precision Medicine and Health

Alessia Costa^{1

2}, Jerome Atutornu^{1

2

3}, Tuba Bircan^{1

2}, Daniela Boraschi², Sasha Henriques^{1

2}, Richard Milne^{1

2}, Lydia Okoibhole^{1

2}, Christine Patch^{1

2}, Anna Middleton^{1

2}

Affiliations

¹ Wellcome Connecting Science, Hinxton, UK.
² Kavli Centre for Ethics, Science, and the Public, University of Cambridge, UK.
³ School of Health and Sports Sciences University of Suffolk, Boston, UK.

Comment

Alessia Costa et al. Am J Bioeth. 2024 Mar.

. 2024 Mar;24(3):89-91.

doi: 10.1080/15265161.2024.2303147. Epub 2024 Feb 23.

¹ Wellcome Connecting Science, Hinxton, UK.
² Kavli Centre for Ethics, Science, and the Public, University of Cambridge, UK.
³ School of Health and Sports Sciences University of Suffolk, Boston, UK.

No abstract available

Comment on

Precision Medicine for Whom? Public Health Outputs from "Genomics England" and "All of Us" to Make Up for Upstream and Downstream Exclusion.
Galasso I. Galasso I. Am J Bioeth. 2024 Mar;24(3):71-85. doi: 10.1080/15265161.2023.2180108. Epub 2023 Mar 6. Am J Bioeth. 2024. PMID: 36876959